investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
Robert M Straubinger
7 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Sihem Ait-Oudhia
University at Buffalo, State University of New York
Buffalo, United States
Donald Mager
University at Buffalo, State University of New York
Buffalo, United States
Arindam Sen
University at Buffalo, State University of New York
Buffalo, United States
Wen Ma
Roswell Park Cancer Institute
Buffalo, United States
Joseph Sperynak
Roswell Park Cancer Institute
Buffalo, United States
Robert O'Connor
Dublin City University
Dublin, Ireland
Christopher Scott
Queen's University Belfast
Belfast, United Kingdom
Robert M Straubinger
University at Buffalo, State University of New York
Buffalo, United States
Related projects
Gwen Lomberk
Novel Experimental Therapeutics for Pancreatic Cancer
Pancreas
Pathology
Maike Sander
A novel mouse model to identify biomarkers of IPMN formation and progression
Pancreas
Pathology
Kenneth P Olive
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer
Pancreas
Pathology
Bryan Q Spring
Online monitoring and image-guided treatment of chemoresistant micrometastases
Pancreas
Pathology
Jonathan Ashwell
T Cell Alternative p38 Activation Pathway – Rockville
Pancreas
Pathology
Christine A Iacobuzio-Donahue
(PQB6) Genetics of Subclonal Evolution in Pancreatic Cancer
Pancreas
Pathology
Channing J Der
Identification of synthetic lethal interactors in pancreatic cancer
Pancreas
Pathology
Eric Collisson
A Genetically Defined System to Identify Factors Essential for KRas Oncogenesis
Pancreas
Pathology
Peng Wei
Genetic Susceptibility and Risk Model for Pancreatic Cancer
Pancreas
Pathology
